To include your compound in the COVID-19 Resource Center, submit it here.

Simeprevir: Phase III data

The open-label, Spanish Phase III PLUTO trial in 40 treatment-naive or -experienced patients with chronic HCV genotype 4 infection showed that once-daily 150 mg Olysio plus 400

Read the full 275 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE